Anupam Rasayan Board Ratifies Luxembourg Acquisitions with USD 50 Million Financing

2 min read     Updated on 12 Feb 2026, 08:00 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Anupam Rasayan India Limited's board meeting on February 12, 2026, ratified the completion of overseas acquisitions in Luxembourg, including Doriath S.à r.l. for EUR 7,024.84 and Batam S.à r.l. for EUR 958.38. The company approved comprehensive financing arrangements totaling USD 50,000,000 through Credit Facilities from Altis XII Pte. Ltd. and External Commercial Borrowing from Axis Bank Limited to support the acquisitions and Target Group acquisition strategy.

32452251

*this image is generated using AI for illustrative purposes only.

Anupam Rasayan India Limited's board has ratified the completion of strategic overseas acquisitions in Luxembourg, marking a significant milestone in the company's international expansion. The board meeting held on February 12, 2026, approved comprehensive financing arrangements totaling USD 50,000,000 to support the acquisitions and broader strategic objectives.

Acquisition Completion Details

The company has successfully completed its Luxembourg expansion through two key acquisitions:

Entity Acquisition Cost Shareholding Completion Status
Doriath S.à r.l. EUR 7,024.84 100% (12,000 shares) Completed February 10, 2026
Batam S.à r.l. EUR 958.38 15% (1,800 shares) Expected February 12, 2026

Doriath S.à r.l., registered with the Luxembourg Trade and Companies Register under number B300157, was incorporated on September 29, 2025. The entity has net assets of EUR 7,024.84 and will provide consultancy services while serving as the affiliate to acquire the Target Group under the Sale and Purchase Agreement with CABB Europe GmbH dated December 9, 2025.

Batam S.à r.l., registered under number B301756 and incorporated on November 14, 2025, has net assets of EUR 6,389.19. The company will undertake significant consultancy services including financial services, with Anupam Rasayan intending to assist in its business activities.

Major Financing Arrangements

The board has approved substantial financing structures to support the acquisitions:

Facility Type Amount Source Purpose
Credit Facilities USD 20,000,000 Altis XII Pte. Ltd. Fund Target Group acquisition by Doriath
External Commercial Borrowing USD 30,000,000 Axis Bank Limited, IBU GIFT City Overseas Direct Investment loan to Doriath

The Credit Facilities will be utilized to fund the partial consideration for Doriath's acquisition of 100% share capital in the Target and an intragroup loan receivable. The ECB Facility proceeds will be used for Overseas Direct Investment in Doriath through a loan not exceeding USD 20,000,000.

Security and Corporate Structure

The acquisitions involve comprehensive security arrangements and corporate guarantees:

  • First ranking pari passu charge by way of hypothecation over movable fixed assets
  • First ranking pari passu charge by way of mortgage over identified immovable properties
  • Exclusive pledge over shares held in the acquired companies
  • Contractual non-disposal undertaking over shares in Tanfac Industries Limited

Catalyst Trusteeship Limited has been appointed as the onshore security trustee for the Credit Facilities, while Axis Trustee Services Limited will serve as the security agent for the ECB Facility.

Strategic Business Rationale

The primary objective of these acquisitions is to create a corporate presence in Luxembourg, expanding the company's international footprint. Both entities will focus on consultancy services, with Doriath playing a crucial role in the broader Target Group acquisition strategy involving Monitchem Kansas S.à r.l and its subsidiaries. The acquisitions do not fall within related party transactions, and the promoter group has no interest in the entities being acquired.

Source:

Historical Stock Returns for Anupam Rasayan

1 Day5 Days1 Month6 Months1 Year5 Years
-2.32%+2.32%+1.79%+17.45%+93.19%+153.68%

Anupam Rasayan India Limited Schedules Q3FY26 Earnings Call for February 14, 2026

1 min read     Updated on 10 Feb 2026, 06:47 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Anupam Rasayan India Limited has scheduled its Q3FY26 earnings call for February 14, 2026, at 15:00 hrs IST to discuss financial results for the quarter and nine months ended December 31, 2025. The call will feature senior management including MD Mr. Anand Desai, CEO Mr. Gopal Agrawal, and CFO Mr. Amit Khurana. The specialty chemicals manufacturer serves 71+ customers including 27+ multinationals through six Gujarat-based facilities with 30,000 MT aggregate capacity.

32275061

*this image is generated using AI for illustrative purposes only.

Anupam Rasayan India Limited has scheduled its earnings call to discuss the financial performance for the third quarter and nine months of Financial Year 2025-26. The company will announce its unaudited financial results for the quarter and nine months ended December 31, 2025, followed by a management discussion on February 14, 2026.

Earnings Call Details

The earnings conference call is scheduled for Saturday, February 14, 2026, at 15:00 hrs IST. The company has made comprehensive arrangements for stakeholder participation through multiple access channels.

Parameter: Details
Date: Saturday, February 14, 2026
Time: 15:00 hrs IST
Universal Access Numbers: +91 22 6280 1107, +91 22 7115 8008
USA Toll-Free: 18667462133
UK Toll-Free: 08081011573
Singapore Toll-Free: 8001012045
Hong Kong Toll-Free: 800964448

Management Representation

The earnings call will feature senior management representatives who will discuss the company's financial performance and business developments:

  • Mr. Anand Desai - Managing Director
  • Mr. Gopal Agrawal - Chief Executive Officer
  • Mr. Amit Khurana - Chief Financial Officer
  • Mr. Vishal Thakkar - Deputy Chief Financial Officer

Participants are requested to dial-in 5 minutes before the scheduled time to ensure smooth connectivity.

Company Overview

Anupam Rasayan India Limited is a leading specialty chemicals manufacturer incorporated in 1984, specializing in custom synthesis and manufacturing. The company operates through two main verticals: Life Science related Specialty Chemicals covering Agrochemicals, Personal Care and Pharmaceuticals, and Other Specialty Chemicals including Specialty Pigments, Dyes, and Polymer Additives.

Business Parameter: Details
Customer Base: 71+ domestic and international customers
Multinational Clients: 27+ companies
Manufacturing Facilities: 6 facilities in Gujarat
Facility Locations: 4 at Sachin, Surat; 2 at Jhaghadia, Bharuch
Aggregate Installed Capacity: About 30,000 MT as of March 31, 2025

Regulatory Compliance

The earnings call announcement has been made in compliance with Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has informed both BSE Limited and National Stock Exchange of India Limited about the scheduled earnings call, with the intimation also hosted on the company's website at www.anupamrasayan.com .

Historical Stock Returns for Anupam Rasayan

1 Day5 Days1 Month6 Months1 Year5 Years
-2.32%+2.32%+1.79%+17.45%+93.19%+153.68%

More News on Anupam Rasayan

1 Year Returns:+93.19%